Cargando…
Sodium Butyrate Ameliorates Type 2 Diabetes-Related Sarcopenia Through IL-33-Independent ILC2s/IL-13/STAT3 Signaling Pathway
PURPOSE: Sarcopenia has been described as a new complication of type 2 diabetes mellitus (T2DM). T2DM and sarcopenia impact each other, resulting in a variety of adverse outcomes such as frailty, disability, poor quality of life and increased mortality. Sodium butyrate (NaB) is reported to play a pr...
Autores principales: | Cao, Yuan, Li, Yulin, Han, Wenqiang, Jia, Xu, Zhu, Ping, Wei, Bin, Cong, Xiaoyan, Wang, Zhihao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888475/ https://www.ncbi.nlm.nih.gov/pubmed/36733489 http://dx.doi.org/10.2147/JIR.S392350 |
Ejemplares similares
-
IL-15 sustains IL-7R-independent ILC2 and ILC3 development
por: Robinette, Michelle L., et al.
Publicado: (2017) -
IL-33 and the PKA Pathway Regulate ILC2 Populations Expressing IL-9 and ST2
por: Olguín-Martínez, Enrique, et al.
Publicado: (2022) -
A role for IL-33–activated ILC2s in eosinophilic vasculitis
por: Kotas, Maya E., et al.
Publicado: (2021) -
c-Rel Is Required for IL-33-Dependent Activation of ILC2s
por: Zaini, Aidil, et al.
Publicado: (2021) -
The IL-33-ILC2 pathway protects from amebic colitis
por: Uddin, Md Jashim, et al.
Publicado: (2021)